Mouse and cellular models of KPTN-related disorder implicate mTOR signalling in cognitive and progressive overgrowth phenotypes

KPTN-related disorder (KRD) is an autosomal recessive disorder associated with germline variants in KPTN (kaptin), a component of the mTOR regulatory complex KICSTOR. To gain further insights into the pathogenesis of KRD, we analysed mouse knockout and human stem cell KPTN loss-of-function models. Kptn−/− mice display many of the key KRD phenotypes, including brain overgrowth, behavioural abnormalities, and cognitive deficits. Assessment of affected individuals has identified concordant selectivity of cognitive deficits, postnatal onset of brain overgrowth, and a previously unrecognised KPTN dosage-sensitivity, resulting in increased head circumference in their heterozygous parents. Molecular and structural analysis of Kptn−/− mice revealed pathological changes, including differences in brain size, shape, and cell numbers primarily due to abnormal postnatal brain development. Both the mouse and differentiated iPSC models of the disorder display transcriptional and biochemical evidence for altered mTOR pathway signalling, supporting the role of KPTN in regulating mTORC1. Increased mTOR signalling downstream of KPTN is rapamycin sensitive, highlighting possible therapeutic avenues with currently available mTOR inhibitors. These findings place KRD in the broader group of mTORC1 related disorders affecting brain structure, cognitive function, and network integrity.

[1]  Max W. Y. Lam,et al.  The impact of rare protein coding genetic variation on adult cognitive function , 2022, Nature Genetics.

[2]  M. Hurles,et al.  Rare genetic variants impact muscle strength , 2022, medRxiv.

[3]  T. Frayling,et al.  Rare genetic variants in genes and loci linked to dominant monogenic developmental disorders cause milder related phenotypes in the general population , 2022, American journal of human genetics.

[4]  Ronen E. Mukamel,et al.  A spectrum of recessiveness among Mendelian disease variants in UK Biobank , 2021, medRxiv.

[5]  Evan Z. Macosko,et al.  Molecular logic of cellular diversification in the mouse cerebral cortex , 2021, Nature.

[6]  D. Wishart,et al.  Neural crest-specific loss of Bmp7 leads to midfacial hypoplasia, nasal airway obstruction and disordered breathing, modeling obstructive sleep apnea , 2021, Disease Models & Mechanisms.

[7]  Patrick J. Short,et al.  Evidence for 28 genetic disorders discovered by combining healthcare and research data , 2020, Nature.

[8]  P. Lapunzina,et al.  Pathogenic variants in KPTN, a rare cause of macrocephaly and intellectual disability , 2020, American journal of medical genetics. Part A.

[9]  Madeline G. Andrews,et al.  mTOR signaling regulates the morphology and migration of outer radial glia in developing human cortex , 2020, bioRxiv.

[10]  Seonhee Kim,et al.  Multimodal Analysis of STRADA Function in Brain Development , 2020, Frontiers in Cellular Neuroscience.

[11]  Neil A. Miller,et al.  Pathogenic variants in KPTN gene identified by clinical whole-genome sequencing , 2020, Cold Spring Harbor molecular case studies.

[12]  M. Somerman,et al.  Dental and craniofacial defects in the Crtap−/− mouse model of osteogenesis imperfecta type VII , 2020, Developmental dynamics : an official publication of the American Association of Anatomists.

[13]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[14]  J. Martinez-Agosto,et al.  Mutations in the sonic hedgehog pathway cause macrocephaly‐associated conditions due to crosstalk to the PI3K/AKT/mTOR pathway , 2019, American journal of medical genetics. Part A.

[15]  N. Matsumoto,et al.  Constitutive activation of mTORC1 signaling induced by biallelic loss-of-function mutations in SZT2 underlies a discernible neurodevelopmental disease , 2019, PloS one.

[16]  Jacqueline K. White,et al.  Large-scale neuroanatomical study uncovers 198 gene associations in mouse brain morphogenesis , 2019, Nature Communications.

[17]  Fiona Cunningham,et al.  Flexible and scalable diagnostic filtering of genomic variants using G2P with Ensembl VEP , 2019, Nature Communications.

[18]  J. Vilo,et al.  g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update) , 2019, Nucleic Acids Res..

[19]  Ian T. Fiddes,et al.  Establishing Cerebral Organoids as Models of Human-Specific Brain Evolution , 2018, Cell.

[20]  P. Lapunzina,et al.  mTOR mutations in Smith‐Kingsmore syndrome: Four additional patients and a review , 2018, Clinical genetics.

[21]  Delong Meng,et al.  mTOR signaling in stem and progenitor cells , 2018, Development.

[22]  S. Linnarsson,et al.  Conserved properties of dentate gyrus neurogenesis across postnatal development revealed by single-cell RNA sequencing , 2018, Nature Neuroscience.

[23]  R. Pfundt,et al.  Variation in a range of mTOR-related genes associates with intracranial volume and intellectual disability , 2017, Nature Communications.

[24]  Angela N. Brooks,et al.  A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles , 2017, Cell.

[25]  Davis J. McCarthy,et al.  Common genetic variation drives molecular heterogeneity in human iPSCs , 2017, Nature.

[26]  J. Hansen,et al.  Epilepsy-causing sequence variations in SIK1 disrupt synaptic activity response gene expression and affect neuronal morphology , 2016, European Journal of Human Genetics.

[27]  Yi-wu Shi,et al.  Epilepsy-associated genes , 2017, Seizure.

[28]  J. Jaworski,et al.  Molecular neurobiology of mTOR , 2017, Neuroscience.

[29]  Gu,et al.  KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1 , 2017, Nature.

[30]  A. Brivanlou,et al.  combined small-molecule inhibition accelerates the derivation of functional cortical neurons from human pluripotent stem cells , 2017 .

[31]  T. Tsunoda,et al.  A combination of genetic and biochemical analyses for the diagnosis of PI3K-AKT-mTOR pathway-associated megalencephaly , 2017, BMC Medical Genetics.

[32]  J. Martinez-Agosto,et al.  Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies , 2016, American journal of medical genetics. Part C, Seminars in medical genetics.

[33]  J. French,et al.  Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study , 2016, The Lancet.

[34]  B. Yalcin,et al.  Histomorphological Phenotyping of the Adult Mouse Brain , 2016, Current protocols in mouse biology.

[35]  S. Sawiak,et al.  BCL11A Haploinsufficiency Causes an Intellectual Disability Syndrome and Dysregulates Transcription , 2016, American journal of human genetics.

[36]  H. Lerche,et al.  Novel KCNQ3 Mutation in a Large Family with Benign Familial Neonatal Epilepsy: A Rare Cause of Neonatal Seizures , 2016, Molecular Syndromology.

[37]  A. Tee,et al.  The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex. , 2016, Seminars in cell & developmental biology.

[38]  E. Valjent,et al.  Ribosomal Protein S6 Phosphorylation in the Nervous System: From Regulation to Function , 2015, Front. Mol. Neurosci..

[39]  D. Valle,et al.  GeneMatcher: A Matching Tool for Connecting Investigators with an Interest in the Same Gene , 2015, Human mutation.

[40]  David W. Nauen,et al.  Single-Cell RNA-Seq with Waterfall Reveals Molecular Cascades underlying Adult Neurogenesis. , 2015, Cell stem cell.

[41]  S. Pajusalu,et al.  Novel homozygous mutation in KPTN gene causing a familial intellectual disability‐macrocephaly syndrome , 2015, American journal of medical genetics. Part A.

[42]  Alejandro Sifrim,et al.  Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data , 2015, The Lancet.

[43]  M. Shinawi,et al.  De novo mutations in SIK1 cause a spectrum of developmental epilepsies. , 2015, American journal of human genetics.

[44]  P. Crino.  mTOR signaling in epilepsy: insights from malformations of cortical development. , 2015, Cold Spring Harbor perspectives in medicine.

[45]  Seok-Gu Kang,et al.  Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy , 2015, Nature Medicine.

[46]  Beth K. Martin,et al.  Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia , 2015, Annals of neurology.

[47]  M. L. Seibenhener,et al.  Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice. , 2015, Journal of visualized experiments : JoVE.

[48]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[49]  G. Condorelli,et al.  mTOR regulates brain morphogenesis by mediating GSK3 signaling , 2014, Development.

[50]  J. Lipton,et al.  The Neurology of mTOR , 2014, Neuron.

[51]  H. Soares,et al.  Suppression of Feedback Loops Mediated by PI3K/mTOR Induces Multiple Overactivation of Compensatory Pathways: An Unintended Consequence Leading to Drug Resistance , 2014, Molecular Cancer Therapeutics.

[52]  M. Knobloch,et al.  SPOT14-Positive Neural Stem/Progenitor Cells in the Hippocampus Respond Dynamically to Neurogenic Regulators , 2014, Stem cell reports.

[53]  Bruce J. Melancon,et al.  Selective Activation of M4 Muscarinic Acetylcholine Receptors Reverses MK-801-Induced Behavioral Impairments and Enhances Associative Learning in Rodents , 2014, ACS chemical neuroscience.

[54]  H. Cross,et al.  Mutations in KPTN Cause Macrocephaly, Neurodevelopmental Delay, and Seizures , 2014, American journal of human genetics.

[55]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[56]  Guy B. Williams,et al.  Voxel-based morphometry with templates and validation in a mouse model of Huntington’s disease , 2013, Magnetic resonance imaging.

[57]  A. Bordey,et al.  mTORC1 targets the translational repressor 4E-BP2, but not S6 kinase 1/2, to regulate neural stem cell self-renewal in vivo. , 2013, Cell reports.

[58]  Timothy J Bussey,et al.  The touchscreen operant platform for testing learning and memory in rats and mice , 2013, Nature Protocols.

[59]  Dvir Dahary,et al.  Biallelic SZT2 mutations cause infantile encephalopathy with epilepsy and dysmorphic corpus callosum. , 2013, American journal of human genetics.

[60]  Damian Smedley,et al.  Genome-wide Generation and Systematic Phenotyping of Knockout Mice Reveals New Roles for Many Genes , 2013, Cell.

[61]  L. Saksida,et al.  GluN2B in corticostriatal circuits governs choice learning and choice shifting , 2013, Nature Neuroscience.

[62]  K. Blomgren,et al.  Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species , 2013, Progress in Neurobiology.

[63]  R. Weksberg,et al.  Molecular Mechanisms of Childhood Overgrowth , 2013, American journal of medical genetics. Part C, Seminars in medical genetics.

[64]  K. Strauss,et al.  Rapamycin Prevents Seizures After Depletion of STRADA in a Rare Neurodevelopmental Disorder , 2013, Science Translational Medicine.

[65]  Alicia Izquierdo,et al.  Basolateral Amygdala Lesions Facilitate Reward Choices after Negative Feedback in Rats , 2013, The Journal of Neuroscience.

[66]  S. Elledge,et al.  Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATR. , 2013, Cancer research.

[67]  M. Araúzo-Bravo,et al.  Metabolic control of adult neural stem cell activity by Fasn-dependent lipogenesis , 2012, Nature.

[68]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[69]  A. Klintsova,et al.  Long-Term Consequences of Developmental Alcohol Exposure on Brain Structure and Function: Therapeutic Benefits of Physical Activity , 2012, Brain sciences.

[70]  S. Gabriel,et al.  De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly , 2012, Nature Genetics.

[71]  P. Dash,et al.  The differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex. , 2012, Human molecular genetics.

[72]  Maria K. Lehtinen,et al.  Somatic Activation of AKT3 Causes Hemispheric Developmental Brain Malformations , 2012, Neuron.

[73]  L. Saksida,et al.  New translational assays for preclinical modelling of cognition in schizophrenia: The touchscreen testing method for mice and rats , 2012, Neuropharmacology.

[74]  P. Crino.  mTOR: A pathogenic signaling pathway in developmental brain malformations. , 2011, Trends in molecular medicine.

[75]  J. Vega,et al.  3D-μCT Cephalometric Measurements in Mice , 2011 .

[76]  J. Harrow,et al.  A conditional knockout resource for the genome-wide study of mouse gene function , 2011, Nature.

[77]  J. Rubenstein,et al.  Annual Research Review: Development of the cerebral cortex: implications for neurodevelopmental disorders. , 2011, Journal of child psychology and psychiatry, and allied disciplines.

[78]  Jayanta Debnath,et al.  Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease , 2010, PloS one.

[79]  E. Klann,et al.  mTOR signaling: At the crossroads of plasticity, memory and disease , 2010, Trends in Neurosciences.

[80]  C. Mahaffey,et al.  Szt2, a novel gene for seizure threshold in mice , 2009, Genes, brain, and behavior.

[81]  Manuel Corpas,et al.  DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. , 2009, American journal of human genetics.

[82]  Frederico A. C. Azevedo,et al.  Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled‐up primate brain , 2009, The Journal of comparative neurology.

[83]  M. P. McDonald,et al.  Endogenous anxiety and stress responses in water maze and Barnes maze spatial memory tasks , 2009, Behavioural Brain Research.

[84]  Michael P. Stryker,et al.  Reversing Neurodevelopmental Disorders in Adults , 2008, Neuron.

[85]  Alcino J. Silva,et al.  Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis , 2008, Nature Medicine.

[86]  Jeffrey M. Zacks,et al.  Neural substrates of narrative comprehension and memory , 2008, NeuroImage.

[87]  B. Manning,et al.  The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. , 2008, The Biochemical journal.

[88]  R. Lin,et al.  Rapamycin and mTOR kinase inhibitors , 2008, Journal of chemical biology.

[89]  Paolo Cignoni,et al.  MeshLab: an Open-Source Mesh Processing Tool , 2008, Eurographics Italian Chapter Conference.

[90]  John D. Storey,et al.  Capturing Heterogeneity in Gene Expression Studies by Surrogate Variable Analysis , 2007, PLoS genetics.

[91]  A. Tomarken,et al.  Spatial and nonspatial escape strategies in the Barnes maze. , 2006, Learning & memory.

[92]  I. Grummt,et al.  Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases , 2006, Oncogene.

[93]  C. Proud,et al.  The mTOR pathway in the control of protein synthesis. , 2006, Physiology.

[94]  S. Chanda,et al.  Measuring cognitive deficits in disabled mice using an automated interactive touchscreen system , 2006, Nature Methods.

[95]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[96]  O. Meyuhas,et al.  Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. , 2006, Trends in biochemical sciences.

[97]  K. Kendrick,et al.  Neural encoding of olfactory recognition memory. , 2005, The Journal of reproduction and development.

[98]  A. Stewart,et al.  A reliable lacZ expression reporter cassette for multipurpose, knockout‐first alleles , 2004, Genesis.

[99]  H. Zoghbi.  Postnatal Neurodevelopmental Disorders: Meeting at the Synapse? , 2003, Science.

[100]  S. Baker,et al.  mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[101]  T. Robbins,et al.  Dissociable Contributions of the Orbitofrontal and Infralimbic Cortex to Pavlovian Autoshaping and Discrimination Reversal Learning: Further Evidence for the Functional Heterogeneity of the Rodent Frontal Cortex , 2003, The Journal of Neuroscience.

[102]  A. Blokland,et al.  Assessment of spatial learning abilities of mice in a new circular maze , 2003, Physiology & Behavior.

[103]  M. Hascöet,et al.  The mouse light/dark box test. , 2003, European journal of pharmacology.

[104]  Thomas R. Insel,et al.  The Neuroendocrine Basis of Social Recognition , 2002, Frontiers in Neuroendocrinology.

[105]  P. Burger,et al.  Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease , 2001, Nature Genetics.

[106]  T. Insel,et al.  Oxytocin in the Medial Amygdala is Essential for Social Recognition in the Mouse , 2001, The Journal of Neuroscience.

[107]  M. Rogawski.  KCNQ2/KCNQ3 K+ channels and the molecular pathogenesis of epilepsy: implications for therapy , 2000, Trends in Neurosciences.

[108]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[109]  J. Heitman,et al.  The TOR signaling cascade regulates gene expression in response to nutrients. , 1999, Genes & development.

[110]  T J Cole,et al.  British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood. , 1998, Statistics in medicine.

[111]  F. Goodwin,et al.  Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines , 1980, Pharmacology Biochemistry and Behavior.